Oral Presentations

• Association of erythropoietin resistance and fibroblast growth factor 23 in dialysis patients: Results from the J-DOPPS (Oral # TH-OR030)
• International peritoneal dialysis training practices and the risk of peritonitis (Oral # FR-OR109)
• Peritoneal dialysis modality and interference in daily life: Results from the PDOPPS (Oral # FR-OR108)
• Hyperkalemia excursions and mortality in hemodialysis patients: Results from the DOPPS (Oral # SA-OR067)
• Urban segregation and hospitalization outcomes in patients on hemodialysis (Oral # SA-OR060)

Poster Presentations

• Pruritus and mortality in hemodialysis patients: Results from the international DOPPS (Poster # TH-PO243)
• Pruritus and patient reported outcomes (PROs): Associations between the Skindex-10 and PROs in hemodialysis patients (Poster # TH-PO244)
• PTH levels prior to initiating hemodialysis: Associations with prescription of PTH-lowering therapies and risk of uncontrolled PTH during the first (Poster # FR-PO128)
• Etelcalcetide utilization and CKD-MBD marker responses in US hemodialysis patients (Poster # FR-PO135)
• Dialysate citrate and mortality in the Dialysis Outcomes and Practice Patterns Study (Poster # FR-PO484)
• International variation in outcomes after peritoneal dialysis-related peritonitis (Poster # FR-PO534)
• Patterns of care for lipid management in CKD Stage 3-5 patients: Results from the CKDopps (Poster # SA-PO883)

Topic and Speaker:
The DOPPS Odyssey: Reducing unwarranted practice variation really does improve dialysis patient outcomes! – Bruce Robinson
Wednesday, October 2, 2019: 10:00 AM - 10:45 AM

Symposium: Update from the DOPPS Program: Centering care around patients
Sunday, September 15, 2019: 11:00 AM - 12:30 PM
Hall A2

Topics and Speakers:

• DOPPS: Associations of self-reported physical activity types and levels with quality of life, depression symptoms, and mortality in haemodialysis patients - Jennie King
• PDOPPS: Perceptions about the dialysis modality decision process among peritoneal dialysis and in-centre haemodialysis patients - Anna Marti i Monros
• CKDopps: Coping with kidney disease - qualitative findings from the Empowering Patients on Choices for Renal Replacement Therapy (EPOCH-RRT) study - Michel Roden
• Patient perspectives on the choice of dialysis modality: Results from the Empowering Patients on Choices for Renal Replacement Therapy (EPOCH-RRT) study -  Marisa Pegoraro

Symposium:
Friday, September 6, 2019: 2:00 PM - 3:40 PM
Nagoya Congress Center

Topics and Speakers:

• PDOPPS: Current status of worldwide PDOPPS – Jeffrey Perl 
• Treatment and Prevention of Peritoneal Dialysis Related Infections in PDOPPS – Neil Boudville
• Novel Insights in PD First Policy from PDOPPS – Talerngsak Kanjanabuch
• Expectation and Influence of PDOPPS to Japan – Kawanishi H

DOPPS Symposium
June 29, 2019, presentation begins at 4:20 p.m.

Poster Presentations
Friday, June 14

• Kt/V Achievement and Mortality in Hemodialysis Patients in the Gulf Cooperation Council (GCC) Countries: Results from DOPPS (2012-2018) (Poster #FP530)

Saturday, June 15

• Impact of long term serum phosphorus control on cardiovascular mortality using a 6-month area under the curve approach in the DOPPS (Poster #SP603)
• Hemoglobin, Patient-Reported Physical Activity, and Risk of Death and CKD Progression in Stage 3-5 CKD Patients: Results from CKDopps (Poster #SP329)

Symposium: Listening to patients to improve outcomes for persons nearing kidney failure or on dialysis
Friday, April 12, 2019: 2:00 PM - 4:00 PM
Session Chairs: Simon Davies and Allison Tong
Topics and Speakers:

• Shared decision making regarding treatment options for kidney failure – Roberto Pecoits-Filho
• Advantages and disadvantages of peritoneal dialysis: what do patients tell us? – Angela Yee Moon Wang
• Expanding options for frail persons with kidney failure: assisted home dialysis, dialysis avoidance, and dialysis withdrawal – Norio Hanafusa
• Empowering dialysis patients: Understanding and improving patient-provider connections – Lalita Subramanian